Veterinary Product Information
Vet > Papillomune

Papillomune

This page contains information on Papillomune for veterinary use.
The information provided typically includes the following:
  • Papillomune Indications
  • Warnings and cautions for Papillomune
  • Direction and dosage information for Papillomune

Papillomune

This treatment applies to the following species:
Manufacturer: AgriLabs

Bovine Wart Vaccine

Killed Virus

Description

PAPILLOMUNE™ contains a standardized, inactivated concentration of virus-laden tissue extract derived from bovine papillomas. The antigenic concentration contained in PAPILLOMUNE exceeds the minimum volume set by USDA and is labeled for a uniform 10ml dose. PAPILLOMUNE is a uniformly clear, homogenous suspension that is easily syringeable.

This vaccine is available in 5 dose (50ml) vials as well as in convenient single dose vials for the owner of a single animal planned for juried showing. No need to purchase more than is needed or to risk contaminating multi-dose vials by storing and re-entering. Field testing of several hundred animals demonstrated PAPILLOMUNE to be safe, with no adverse reactions. Injection site swelling was minimal and of short duration.

In animals destined for the show-ring, and in seedstock cattle, warts (papillomas) can seriously impair the aesthetic, and ultimately the economic value of the animal. Benign, self limiting tumors, warts in cattle are caused by bovine papilloma virus. The virus replicates within the wart tissue with a great deal of the infective virus residing near the surface. When affected animals rub against fences, stanchions or other objects, they may transfer infective virus to the object leaving others in the herd vulnerable to infection should they receive skin abrasions from these objects.

Papillomune Indications

PAPILLOMUNE is indicated for use as an aid in the prevention of viral warts in cattle. Vaccinate only healthy animals.

Vaccination

Vaccinate healthy animals with 10ml subcutaneously in two sites on the animal.

Procedures

(5ml each) using aseptic technique. Repeat dose in 3-5 weeks. Because the papilloma virus is so environmentally stable, many experienced bovine practitioners suggest continuation of the vaccination regime for at least one year after the last warts have been observed in a herd.

Administration

Shake well before using. Using aseptic technique, subcutaneously administer 10ml of the bacterin. It is suggested that the bacterin be injected forward of the shoulder in the neck region to follow the guidelines of the Beef Quality Assurance Program.

Supplied

10 - single dose vials per carton or 1 - 5 dose vial per carton.

Precautions

Vaccinate only healthy animals. Use entire contents when first opened. Store in the dark at 3°-45°F (2-7°C). This vaccine is a tissue derived extract. In case of anaphylactic reaction use epinephrine or equivalent. Do not vaccinate within 21 days of slaughter. This vaccine is not returnable to the manufacturer.

References

Current Veterinary Therapy, Food Animal Practice, E.B. Saunders Co., 1986: pp. 483-484.

Merck Veterinary Manual, 7th Edition, Merck & Co., Inc. 1991: pp. 854-855.

Agri Laboratories, LTD, P.O. Box 3103, St. Joseph, MO 64503 U.S.A.

U.S. Vet. Lic. No. 368

Phone: (800) 542-8916

www.agrilabs.com

Nac No.

10582030
AGRI LABORATORIES LTD.
20927 STATE ROUTE K, P.O. BOX 3103 (64503), ST. JOSEPH, MO, 64505
Telephone:   816-233-9533
Order Desk:   800-542-8916
Fax:   816-233-9546
Website:   www.agrilabs.com
Every effort has been made to ensure the accuracy of the Papillomune information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.



Advertisement

(web1)